Oct
14
2022

AcouSort’s role in the Blue4Therapy project expands – SEK 700,000 in additional revenue in 2022

The Blue4Therapy project was initiated in May 2020 with the ambition to develop clinical applications in cell therapy and stem cell treatments – two areas with great commercial potential. Behind the project are the University of Southern Denmark, BlueCell Therapeutics, Novozymes and AcouSort. AcouSort’s contribution to the project has been to develop a module for the purification of stem cells in a point-of-care environment.

Read the full press release here.

Läs pressmeddelandet på svenska här.